Christopher J. Kirk - Net Worth and Insider Trading
Christopher J. Kirk Net Worth
The estimated net worth of Christopher J. Kirk is at least $263,775 dollars as of 2024-05-21. Christopher J. Kirk is the President and CSO of Kezar Life Sciences Inc and owns about 342,609 shares of Kezar Life Sciences Inc (KZR) stock worth over $263,775. Details can be seen in Christopher J. Kirk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher J. Kirk has not made any transactions after 2020-02-04 and currently still holds the listed stock(s).
Transaction Summary of Christopher J. Kirk
Christopher J. Kirk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher J. Kirk owns 1 companies in total, including Kezar Life Sciences Inc (KZR) .
Click here to see the complete history of Christopher J. Kirk’s form 4 insider trades.
Insider Ownership Summary of Christopher J. Kirk
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KZR | Kezar Life Sciences Inc | 2020-02-04 | director & President and CSO |
Christopher J. Kirk Latest Holdings Summary
Christopher J. Kirk currently owns a total of 1 stock. Christopher J. Kirk owns 342,609 shares of Kezar Life Sciences Inc (KZR) as of February 4, 2020, with a value of $263,775.
Latest Holdings of Christopher J. Kirk
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KZR | Kezar Life Sciences Inc | 2020-02-04 | 342,609 | 0.77 | 263,775 |
Holding Weightings of Christopher J. Kirk
Christopher J. Kirk Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher J. Kirk has made a total of 3 transactions in Kezar Life Sciences Inc (KZR) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Kezar Life Sciences Inc is the acquisition of 38,461 shares on February 4, 2020, which cost Christopher J. Kirk around $99,999.
Insider Trading History of Christopher J. Kirk
- 1
Christopher J. Kirk Trading Performance
GuruFocus tracks the stock performance after each of Christopher J. Kirk's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher J. Kirk is -4.71%. GuruFocus also compares Christopher J. Kirk's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher J. Kirk within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher J. Kirk's insider trading performs compared to the benchmark.
Performance of Christopher J. Kirk
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.94 | | | | | |
| Relative Return to S&P 500(%) | 8.03 | | | | | |
Christopher J. Kirk Ownership Network
Christopher J. Kirk Owned Company Details
What does Kezar Life Sciences Inc do?
Who are the key executives at Kezar Life Sciences Inc?
Christopher J. Kirk is the director & President and CSO of Kezar Life Sciences Inc. Other key executives at Kezar Life Sciences Inc include 10 percent owner Morningside Venture Investments Ltd , Chief Business Officer Nicholas Michael Mordwinkin , and 10 percent owner Equal Talent Investments Ltd .
Kezar Life Sciences Inc (KZR) Insider Trades Summary
Over the past 18 months, Christopher J. Kirk made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 508,747 shares made by Morningside Venture Investments Ltd ,
In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 508,747 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 508,747 shares.
Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kezar Life Sciences Inc Insider Transactions
Christopher J. Kirk Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher J. Kirk. You might contact Christopher J. Kirk via mailing address: C/o Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
